Company
Comvita Ltd
Headquarters: Te Puke, New Zealand
Employees: 500
Market Cap
NZ$171.3 Million
NZD as of Jan. 1, 2024
US$108.4 Million
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
| Company | Market Cap (USD) |
|---|---|
| Zoetis Inc. | $89.09 B |
| MERCK Kommanditgesellschaft auf Aktien | $67.64 B |
| Takeda Pharmaceutical Company Limited | $47.71 B |
| Haleon plc | $38.90 B |
| PPD, Inc. | $16.58 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
Comvita Limited, together with its subsidiaries, engages in manufacturing and marketing natural health products in Australia, New Zealand, China, rest of Asia, North America, Europe, the Middle East, Africa, and internationally. The company offers Manuka honey, propolis, olive leaf extract, medihoney and skincare, gourmet honey, elixirs and lozenges, and cider vinegar products, as well as oral and kids health products. It also provides solutions for digestive health, eczema prone skin, energy, heart health, and immune support, as well as for summer and travel essentials. In addition, the company engages in the apiary ownership and management, property ownership, and IP ownership. Comvita Limited was incorporated in 1974 and is based in Te Puke, New Zealand.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
Comvita Ltd has the following listings and related stock indices.
Stock: NZX: CVT wb_incandescent